
Signs of carcinogenicity induced by parathion, malathion, and estrogen in human breast epithelial cells (Review)
- Authors:
- Gloria M. Calaf
- Tammy C. Bleak
- Debasish Roy
-
Affiliations: Instituto de Alta Investigación, Universidad de Tarapacá, Arica 1000000, Chile, Department of Natural Sciences, Hostos Community College of The City University of New York, Bronx, NY 10451, USA - Published online on: February 11, 2021 https://doi.org/10.3892/or.2021.7975
- Article Number: 24
-
Copyright: © Calaf et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
![]() |
![]() |
Guyton KZ, Loomis D, Grosse Y, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Scoccianti C, Mattock H and Straif K; International Agency for Research on Cancer Monograph Working Group, IARC, Lyon, France, : Carcinogenicity of tetrachlorvinphos, parathion, malathion, diazinon, and glyphosate. Lancet Oncol. 16:490–491. 2015. View Article : Google Scholar : PubMed/NCBI | |
Rich JD, Gabriel SM and Schultz-Norton JR: In vitro effects of herbicides and insecticides on human breast cells. ISRN Toxicol. 2012:2324612012. View Article : Google Scholar : PubMed/NCBI | |
Lerro CC, Koutros S, Andreotti G, Friesen MC, Alavanja MC, Blair A, Hoppin JA, Sandler DP, Lubin JH, Ma X, et al: Organophosphate insecticide use and cancer incidence among spouses of pesticide applicators in the Agricultural Health Study. Occup Environ Med. 72:736–744. 2015. View Article : Google Scholar : PubMed/NCBI | |
Alavanja MC, Ross MK and Bonner MR: Increased cancer burden among pesticide applicators and others due to pesticide exposure. CA Cancer J Clin. 63:120–142. 2013. View Article : Google Scholar : PubMed/NCBI | |
Sabarwal A, Kumar K and Singh RP: Hazardous effects of chemical pesticides on human health-Cancer and other associated disorders. Environ Toxicol Pharmacol. 63:103–114. 2018. View Article : Google Scholar : PubMed/NCBI | |
Popp J, Peto K and Nagy J: Pesticide productivity and food security. A review. Agron Sustain Dev. 33:243–255. 2013. View Article : Google Scholar | |
Cantor KP, Blair A, Everett G, Gibson R, Burmeister LF, Brown LM, Schuman L and Dick FR: Pesticides and other agricultural risk factors for non-Hodgkin's lymphoma among men in Iowa and Minnesota. Cancer Res. 52:2447–2455. 1992.PubMed/NCBI | |
McDuffie HH, Pahwa P, McLaughlin JR, Spinelli JJ, Fincham S, Dosman JA, Robson D, Skinnider LF and Choi NW: Non-Hodgkin's lymphoma and specific pesticide exposures in men: Cross-Canada study of pesticides and health. Cancer Epidemiol Biomarkers Prev. 10:1155–1163. 2001.PubMed/NCBI | |
Hu L, Luo D, Zhou T, Tao Y, Feng J and Mei S: The association between non-Hodgkin lymphoma and organophosphate pesticides exposure: A meta-analysis. Environ Pollut. 231:319–328. 2017. View Article : Google Scholar : PubMed/NCBI | |
Brown LM, Blair A, Gibson R, Everett GD, Cantor KP, Schuman LM, Burmeister LF, Van Lier SF and Dick F: Pesticide exposures and other agricultural risk factors for leukemia among men in Iowa and Minnesota. Cancer Res. 50:6585–6591. 1990.PubMed/NCBI | |
Soldin OP, Nsouli-Maktabi H, Genkinger JM, Loffredo CA, Ortega-Garcia JA, Colantino D, Barr DB, Luban NL, Shad AT and Nelson D: Pediatric acute lymphoblastic leukemia and exposure to pesticides. Ther Drug Monit. 31:495–501. 2009. View Article : Google Scholar : PubMed/NCBI | |
Costa LG: Organophosphorus compounds at 80: Some old and new issues. Toxicol Sci. 162:24–35. 2018. View Article : Google Scholar : PubMed/NCBI | |
Shen K and Novak RF: DDT stimulates c-erbB2, c-met, and STATS tyrosine phosphorylation, Grb2-Sos association, MAPK phosphorylation, and proliferation of human breast epithelial cells. Biochem Biophys Res Commun. 231:17–21. 1997. View Article : Google Scholar : PubMed/NCBI | |
Bharathi SP, Raj HM, Jain S, Banerjee BD, Ahmed T and Arora VK: Role of pesticides in the induction of tumor angiogenesis. Anticancer Res. 33:231–240. 2013.PubMed/NCBI | |
Dich J, Zahm SH, Hanberg A and Adami HO: Pesticides and cancer. Cancer Causes Control. 8:420–443. 1997. View Article : Google Scholar : PubMed/NCBI | |
Bassil KL, Vakil C, Sanborn M, Cole DC, Kaur JS and Kerr KJ: Cancer health effects of pesticides: Systematic review. Can Fam Physician. 53:1704–1711. 2007.PubMed/NCBI | |
International Agency for Research on Cancer (IARC), . Some organophosphate insecticides and herbicides. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Monograph. 112. IARC; Lyon: 2017, https://monographs.iarc.fr/iarc-monographs-on-the-evaluation-of-carcinogenic-risks-to-humans-4/July. 2017 | |
Blasiak J, Jaloszynski P, Trzeciak A and Szyfter K: In vitro studies on the genotoxicity of the organophosphorus insecticide malathion and its two analogues. Mutat Res. 445:275–283. 1999. View Article : Google Scholar : PubMed/NCBI | |
Berkman CE, Quinn DA and Thompson CM: Interaction of acetylcholinesterase with the enantiomers of malaoxon and isomalathion. Chem Res Toxicol. 6:724–730. 1993. View Article : Google Scholar : PubMed/NCBI | |
Calaf GM and Roy D: Cancer genes induced by malathion and parathion in the presence of estrogen in breast cells. Int J Mol Med. 21:261–268. 2008.PubMed/NCBI | |
Calaf GM and Roy D: Gene and protein expressions induced by 17beta-estradiol and parathion in cultured breast epithelial cells. Mol Med. 13:255–265. 2007. View Article : Google Scholar : PubMed/NCBI | |
International Agency for Research on Cancer (IARC), . Sex Hormones (II). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Monograph. 21. IARC; Lyon: 1979, https://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Sex-Hormones-II-1979January. 2020 | |
International Agency for Research on Cancer (IARC), . Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1–42. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Supplement. 7. IARC; Lyon: 1987, https://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-Supplements/Overall-Evaluations-Of-Carcinogenicity-An-Updating-Of-IARC-Monographs-Volumes-1%E2%80%9342-1987January. 2020PubMed/NCBI | |
International Agency for Research on Cancer (IARC), . Hormonal Contraception and Post-menopausal Hormonal Therapy. IARC Monographs on the Evaluation of Carcinogenic Risks to Human. Monograph. 72. IARC; Lyon: 1999, https://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Hormonal-Contraception-And-Post-menopausal-Hormonal-Therapy-1999January. 2020 | |
Bernstein L and Ross RK: Endogenous hormones and breast cancer risk. Epidemiol Rev. 15:48–65. 1993. View Article : Google Scholar : PubMed/NCBI | |
Henderson BE, Ross R and Bernstein L: Estrogens as a cause of human cancer: The richard and hinda rosenthal foundation award lecture. Cancer Res. 48:246–253. 1988.PubMed/NCBI | |
NRC, . Hormonally Active Agents in the Environmented. National Research Council Washington (DC): The National Academies Press; 1999 | |
Greenman SB, Rutten MJ, Fowler WM, Scheffler L, Shortridge LA, Brown B, Sheppard BC, Deveney KE, Deveney CW and Trunkey DD: Herbicide/pesticide effects on intestinal epithelial growth. Environ Res. 75:85–93. 1997. View Article : Google Scholar : PubMed/NCBI | |
Valeron PF, Pestano JJ, Luzardo OP, Zumbado ML, Almeida M and Boada LD: Differential effects exerted on human mammary epithelial cells by environmentally relevant organochlorine pesticides either individually or in combination. Chem Biol Interact. 180:485–491. 2009. View Article : Google Scholar : PubMed/NCBI | |
Calaf GM and Garrido F: Catechol estrogens as biomarkers for mammary gland cancer. Int J Oncol. 39:177–183. 2011.PubMed/NCBI | |
Calaf GM and Echiburu-Chau C: Synergistic effect of malathion and estrogen on mammary gland carcinogenesis. Oncol Rep. 28:640–646. 2012. View Article : Google Scholar : PubMed/NCBI | |
Echiburu-Chau C and Calaf GM: Rat lung cancer induced by malathion and estrogen. Int J Oncol. 33:603–611. 2008.PubMed/NCBI | |
Calaf GM and Roy D: Gene expression signature of parathion-transformed human breast epithelial cells. Int J Mol Med. 19:741–750. 2007.PubMed/NCBI | |
Calaf GM and Roy D: Human drug metabolism genes in parathion-and estrogen-treated breast cells. Int J Mol Med. 20:875–881. 2007.PubMed/NCBI | |
Calaf GM and Roy D: Cell adhesion proteins altered by 17beta estradiol and parathion in breast epithelial cells. Oncol Rep. 19:165–169. 2008.PubMed/NCBI | |
Calaf GM, Echiburu-Chau C and Roy D: Organophosphorous pesticides and estrogen induce transformation of breast cells affecting p53 and c-Ha-ras genes. Int J Oncol. 35:1061–1068. 2009. View Article : Google Scholar : PubMed/NCBI | |
Calaf G and Russo J: Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis. 14:483–492. 1993. View Article : Google Scholar : PubMed/NCBI | |
Calaf GM and Hei TK: Establishment of a radiation- and estrogen-induced breast cancer model. Carcinogenesis. 21:769–776. 2000. View Article : Google Scholar : PubMed/NCBI | |
Gallardo M and Calaf GM: Curcumin and epithelial-mesenchymal transition in breast cancer cells transformed by low doses of radiation and estrogen. Int J Oncol. 48:2534–2542. 2016. View Article : Google Scholar : PubMed/NCBI | |
Calaf GM: Curcumin, oxidative stress and breast cancer, in Oxidative stress and dietary antioxidants, V. R. Preedy. Elsevier Inc.; London, UK: pp. 159–169. 2014 | |
Calaf GM, Echiburu-Chau C, Roy D, Chai Y, Wen G and Balajee AS: Protective role of curcumin in oxidative stress of breast cells. Oncol Rep. 26:1029–1035. 2011.PubMed/NCBI | |
Guyton KZ, Rieswijk L, Wang A, Chiu WA and Smith MT: Key Characteristics Approach to Carcinogenic Hazard Identification. Chem Res Toxicol. 31:1290–1292. 2018. View Article : Google Scholar : PubMed/NCBI | |
Smith MT, Guyton KZ, Gibbons CF, Fritz JM, Portier CJ, Rusyn I, DeMarini DM, Caldwell JC, Kavlock RJ, Lambert PF, et al: Key Characteristics of carcinogens as a basis for organizing data on mechanisms of carcinogenesis. Environ Health Perspect. 124:713–721. 2016. View Article : Google Scholar : PubMed/NCBI | |
Cabello G, Valenzuela M, Vilaxa A, Duran V, Rudolph I, Hrepic N and Calaf G: A rat mammary tumor model induced by the organophosphorous pesticides parathion and malathion, possibly through acetylcholinesterase inhibition. Environ Health Perspect. 109:471–479. 2001. View Article : Google Scholar : PubMed/NCBI | |
Gwinn MR, Whipkey DL, Tennant LB and Weston A: Differential gene expression in normal human mammary epithelial cells treated with malathion monitored by DNA microarrays. Environ Health Perspect. 113:1046–10451. 2005. View Article : Google Scholar : PubMed/NCBI | |
Calaf GM, Alvarado ME and Hei TK: Beta catenin is associated with breast cancer progression in vitro. Int J Oncol. 26:913–921. 2005.PubMed/NCBI | |
Calaf G and Hei TK: Oncoprotein expression in human breast epithelial cells transformed by high-LET radiation. Int J Radiat Biol. 77:31–40. 2001. View Article : Google Scholar : PubMed/NCBI | |
Nicolson GL: Cell membrane fluid-mosaic structure and cancer metastasis. Cancer Res. 75:1169–1176. 2015. View Article : Google Scholar : PubMed/NCBI | |
Morrissey MA, Hagedorn EJ and Sherwood DR: Cell invasion through basement membrane: The netrin receptor DCC guides the way. Worm. 2:e261692013. View Article : Google Scholar : PubMed/NCBI | |
Naumann K: Synthetic Pyrethroid Insecticides: Structures and Properties. 1 edition. Chemistry of Plant Protection. 4. Berlin, Germany: Springer-Verlag Berlin Heidelberg. XVI, 244. 1990, View Article : Google Scholar | |
Kim IY, Shin JH, Kim HS, Lee SJ, Kang IH, Kim TS, Moon HJ, Choi KS, Moon A and Han SY: Assessing estrogenic activity of pyrethroid insecticides using in vitro combination assays. J Reprod Dev. 50:245–255. 2004. View Article : Google Scholar : PubMed/NCBI | |
Isoda H, Talorete TP, Han J, Oka S, Abe Y and Inamori Y: Effects of organophosphorous pesticides used in china on various mammalian cells. Environ Sci. 12:9–19. 2005.PubMed/NCBI | |
Calaf GM: Susceptibility of human breast epithelial cells in vitro to hormones and drugs. Int J Oncol. 28:285–295. 2006.PubMed/NCBI | |
Fernandez PL, Jares P, Rey MJ, Campo E and Cardesa A: Cell cycle regulators and their abnormalities in breast cancer. Mol Pathol. 51:305–309. 1998. View Article : Google Scholar : PubMed/NCBI | |
Tenga MJ and Lazar IM: Proteomic snapshot of breast cancer cell cycle: G1/S transition point. Proteomics. 13:48–60. 2013. View Article : Google Scholar : PubMed/NCBI | |
Stopper H, Schmitt E, Gregor C, Mueller SO and Fischer WH: Increased cell proliferation is associated with genomic instability: Elevated micronuclei frequencies in estradiol-treated human ovarian cancer cells. Mutagenesis. 18:243–247. 2003. View Article : Google Scholar : PubMed/NCBI | |
Deshpande A, Sicinski P and Hinds PW: Cyclins and cdks in development and cancer: A perspective. Oncogene. 24:2909–2915. 2005. View Article : Google Scholar : PubMed/NCBI | |
Hydbring P, Malumbres M and Sicinski P: Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases. Nat Rev Mol Cell Biol. 17:280–292. 2016. View Article : Google Scholar : PubMed/NCBI | |
Petersen BO, Lukas J, Sorensen CS, Bartek J and Helin K: Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization. EMBO J. 18:396–410. 1999. View Article : Google Scholar : PubMed/NCBI | |
Saxena P: Comparative prediction of binding site of organophosphorus, carbamate and synthetic pyrethroid pesticides on human cyclin-dependent protein kinases Cdk2 and Cdk4. J Entomol Zoology Stud. 2:106–110. 2014. | |
Okuda T, Cleveland JL and Downing JR: PCTAIRE-1 and PCTAIRE-3, two members of a novel cdc2/CDC28-related protein kinase gene family. Oncogene. 7:2249–2258. 1992.PubMed/NCBI | |
Serrano M, Hannon GJ and Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 366:704–707. 1993. View Article : Google Scholar : PubMed/NCBI | |
Kato JY, Matsuoka M, Strom DK and Sherr CJ: Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol Cell Biol. 14:2713–2721. 1994. View Article : Google Scholar : PubMed/NCBI | |
MacLachlan TK, Sang N and Giordano A: Cyclins, cyclin-dependent kinases and cdk inhibitors: Implications in cell cycle control and cancer. Crit Rev Eukaryot Gene Expr. 5:127–156. 1995. View Article : Google Scholar : PubMed/NCBI | |
Tye BK: MCM proteins in DNA replication. Annu Rev Biochem. 68:649–486. 1999. View Article : Google Scholar : PubMed/NCBI | |
Labib K, Tercero JA and Diffley JF: Uninterrupted MCM2-7 function required for DNA replication fork progression. Science. 288:1643–1647. 2000. View Article : Google Scholar : PubMed/NCBI | |
Ryu S and Driever W: Minichromosome maintenance proteins as markers for proliferation zones during embryogenesis. Cell Cycle. 5:1140–1142. 2006. View Article : Google Scholar : PubMed/NCBI | |
Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA and Dynlacht BD: E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev. 16:245–256. 2002. View Article : Google Scholar : PubMed/NCBI | |
Pereverzeva I, Whitmire E, Khan B and Coue M: Distinct phosphoisoforms of the Xenopus Mcm4 protein regulate the function of the Mcm complex. Mol Cell Biol. 20:3667–3676. 2000. View Article : Google Scholar : PubMed/NCBI | |
Ishimi Y, Komamura-Kohno Y, You Z, Omori A and Kitagawa M: Inhibition of Mcm4,6,7 helicase activity by phosphorylation with cyclin A/Cdk2. J Biol Chem. 275:16235–16241. 2000. View Article : Google Scholar : PubMed/NCBI | |
Fujita M, Yamada C, Tsurumi T, Hanaoka F, Matsuzawa K and Inagaki M: Cell cycle- and chromatin binding state-dependent phosphorylation of human MCM heterohexameric complexes. A role for cdc2 kinase. J Biol Chem. 273:17095–17101. 1998. View Article : Google Scholar : PubMed/NCBI | |
Schories B, Engel K, Dorken B, Gossen M and Bommert K: Characterization of apoptosis-induced Mcm3 and Cdc6 cleavage reveals a proapoptotic effect for one Mcm3 fragment. Cell Death Differ. 11:940–942. 2004. View Article : Google Scholar : PubMed/NCBI | |
Koonin EV: A common set of conserved motifs in a vast variety of putative nucleic acid-dependent ATPases including MCM proteins involved in the initiation of eukaryotic DNA replication. Nucleic Acids Res. 21:2541–2547. 1993. View Article : Google Scholar : PubMed/NCBI | |
Helfenstein A, Frahm SO, Krams M, Drescher W, Parwaresch R and Hassenpflug J: Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: Distinction from enchondroma and identification of progressive tumors. Am J Clin Pathol. 122:912–918. 2004. View Article : Google Scholar : PubMed/NCBI | |
Duan X, Yang Y, Wang S, Feng X, Wang T, Wang P, Liu S, Li L, Yao W, Cui L and Wang W: Changes in the expression of genes involved in cell cycle regulation and the relative telomere length in the process of canceration induced by omethoate. Tumour Biol. 39:10104283177197822017. View Article : Google Scholar : PubMed/NCBI | |
Qiu YL, Wang W, Wang T, Liu J, Sun P, Qian J, Jin L and Xia ZL: Genetic polymorphisms, messenger RNA expression of p53, p21, and CCND1, and possible links with chromosomal aberrations in Chinese vinyl chloride-exposed workers. Cancer Epidemiol Biomarkers Prev. 17:2578–2584. 2008. View Article : Google Scholar : PubMed/NCBI | |
Lindstrom MS, Jin A, Deisenroth C, White Wolf G and Zhang Y: Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation. Mol Cell Biol. 27:1056–1068. 2007. View Article : Google Scholar : PubMed/NCBI | |
Lee SS, Bohrson C, Pike AM, Wheelan SJ and Greider CW: ATM kinase is required for telomere elongation in mouse and human cells. Cell Rep. 13:1623–1632. 2015. View Article : Google Scholar : PubMed/NCBI | |
Yang-Snyder J, Miller JR, Brown JD, Lai CJ and Moon RT: A frizzled homolog functions in a vertebrate Wnt signaling pathway. Curr Biol. 6:1302–1306. 1996. View Article : Google Scholar : PubMed/NCBI | |
Sharma M, Castro-Piedras I, Simmons GE Jr and Pruitt K: Dishevelled: A masterful conductor of complex Wnt signals. Cell Signal. 47:52–64. 2018. View Article : Google Scholar : PubMed/NCBI | |
Masckauchan TN, Agalliu D, Vorontchikhina M, Ahn A, Parmalee NL, Li CM, Khoo A, Tycko B, Brown AM and Kitajewski J: Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2. Mol Biol Cell. 17:5163–5172. 2006. View Article : Google Scholar : PubMed/NCBI | |
Sussman DJ, Klingensmith J, Salinas P, Adams PS, Nusse R and Perrimon N: Isolation and characterization of a mouse homolog of the Drosophila segment polarity gene dishevelled. Dev Biol. 166:73–86. 1994. View Article : Google Scholar : PubMed/NCBI | |
Testa JR, Zhou JY, Bell DW and Yen TJ: Chromosomal localization of the genes encoding the kinetochore proteins CENPE and CENPF to human chromosomes 4q24-->q25 and 1q32-->q41, respectively, by fluorescence in situ hybridization. Genomics. 23:691–693. 1994. View Article : Google Scholar : PubMed/NCBI | |
Trinh BN, Ong CN, Coetzee GA, Yu MC and Laird PW: Thymidylate synthase: A novel genetic determinant of plasma homocysteine and folate levels. Hum Genet. 111:299–302. 2002. View Article : Google Scholar : PubMed/NCBI | |
Chang H, Qi X, Trieu Y, Xu W, Reader JC, Ning Y and Reece D: Multiple myeloma patients with CKS1B gene amplification have a shorter progression-free survival post-autologous stem cell transplantation. Br J Haematol. 135:486–491. 2006. View Article : Google Scholar : PubMed/NCBI | |
Russo J, Tahin Q, Lareef MH, Hu YF and Russo IH: Neoplastic transformation of human breast epithelial cells by estrogens and chemical carcinogens. Environ Mol Mutagen. 39:254–263. 2002. View Article : Google Scholar : PubMed/NCBI | |
Reynolds FH Jr, Todaro GJ, Fryling C and Stephenson JR: Human transforming growth factors induce tyrosine phosphorylation of EGF receptors. Nature. 292:259–262. 1981. View Article : Google Scholar : PubMed/NCBI | |
Hines SJ, Litz JS and Krystal GW: Coexpression of c-kit and stem cell factor in breast cancer results in enhanced sensitivity to members of the EGF family of growth factors. Breast Cancer Res Treat. 58:1–10. 1999. View Article : Google Scholar : PubMed/NCBI | |
Wee P and Wang Z: Epidermal growth factor receptor cell proliferation signaling pathways. Cancers (Basel). 9:522017. View Article : Google Scholar | |
Wang Z: ErbB receptors and cancer. Methods Mol Biol. 1652:3–35. 2017. View Article : Google Scholar : PubMed/NCBI | |
Nicholson RI, Gee JM and Harper ME: EGFR and cancer prognosis. Eur J Cancer. 37 (Suppl 4):S9–S15. 2001. View Article : Google Scholar : PubMed/NCBI | |
Lippman M, Bolan G and Huff K: The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 36:4595–4601. 1976.PubMed/NCBI | |
Dickson RB and Lippman ME: Control of human breast cancer by estrogen, growth factors, and oncogenes. Cancer Treat Res. 40:119–165. 1988. View Article : Google Scholar : PubMed/NCBI | |
Yamamoto KR: Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet. 19:209–252. 1985. View Article : Google Scholar : PubMed/NCBI | |
Marino M, Galluzzo P and Ascenzi P: Estrogen signaling multiple pathways to impact gene transcription. Curr Genomics. 7:497–508. 2006. View Article : Google Scholar : PubMed/NCBI | |
Pratt WB and Toft DO: Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev. 18:306–360. 1997. View Article : Google Scholar : PubMed/NCBI | |
Yasar P, Ayaz G, User SD, Gupur G and Muyan M: Molecular mechanism of estrogen-estrogen receptor signaling. Reprod Med Biol. 16:4–20. 2017. View Article : Google Scholar : PubMed/NCBI | |
Safe S: Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions. Vitam Horm. 62:231–252. 2001. View Article : Google Scholar : PubMed/NCBI | |
Bjornstrom L and Sjoberg M: Mutations in the estrogen receptor DNA-binding domain discriminate between the classical mechanism of action and cross-talk with Stat5b and activating protein 1 (AP-1). J Biol Chem. 277:48479–48483. 2002. View Article : Google Scholar : PubMed/NCBI | |
Garcia-Becerra R, Santos N, Diaz L and Camacho J: Mechanisms of resistance to endocrine therapy in breast cancer: Focus on signaling pathways, miRNAs and genetically based resistance. Int J Mol Sci. 14:108–145. 2012. View Article : Google Scholar : PubMed/NCBI | |
Felipe Lima J, Nofech-Mozes S, Bayani J and Bartlett JM: EMT in breast carcinoma-a review. J Clin Med. 5:652016. View Article : Google Scholar | |
Calaf GM, Bleak TC, Munoz JP and Aguayo F: Markers of epithelial-mesenchymal transition in an experimental breast cancer model induced by organophosphorous pesticides and estrogen. Oncol Lett. 20:842020. View Article : Google Scholar : PubMed/NCBI | |
Conney AH, Welch RM, Kuntzman R and Burns JJ: Effects of pesticides on drug and steroid metabolism. Clin Pharmacol Ther. 8:2–10. 1967. View Article : Google Scholar : PubMed/NCBI | |
Taxak N and Bharatam PV: Drug metabolism: A fascinating link between chemistry and biology. Resonance. 19:259–282. 2014. View Article : Google Scholar | |
Di L and Kerns EH: Metabolic Stability, in Drug-Like Properties: Concepts, Structure Design and Methods from ADME to Toxicity Optimization, E. H. K. Li Di. Elsevier; pp. 161–194. 2016 | |
Chen TL, Lin CJ and Liu CC: Cytochrome P450-dependent monooxygenase system and anesthetics. Acta Anaesthesiol Sin. 33:185–194. 1995.(In Chinese). PubMed/NCBI | |
Bernstein L, Ross RK, Pike MC, Brown JB and Henderson BE: Hormone levels in older women: A study of post-menopausal breast cancer patients and healthy population controls. Br J Cancer. 61:298–302. 1990. View Article : Google Scholar : PubMed/NCBI | |
Dubey RK and Jackson EK: Estrogen-induced cardiorenal protection: Potential cellular, biochemical, and molecular mechanisms. Am J Physiol Renal Physiol. 280:F365–F388. 2001. View Article : Google Scholar : PubMed/NCBI | |
Yue W, Santen RJ, Wang JP, Li Y, Verderame MF, Bocchinfuso WP, Korach KS, Devanesan P, Todorovic R, Rogan EG and Cavalieri EL: Genotoxic metabolites of estradiol in breast: Potential mechanism of estradiol induced carcinogenesis. J Steroid Biochem Mol Biol. 86:477–486. 2003. View Article : Google Scholar : PubMed/NCBI | |
Williamson LM and Lees-Miller SP: Estrogen receptor alpha-mediated transcription induces cell cycle-dependent DNA double-strand breaks. Carcinogenesis. 32:279–285. 2011. View Article : Google Scholar : PubMed/NCBI | |
Yang KJ, Lee J and Park HL: Organophosphate pesticide exposure and breast cancer risk: A rapid review of human, animal, and cell-based studies. Int J Environ Res Public Health. 17:50302020. View Article : Google Scholar | |
Telang NT, Suto A, Wong GY, Osborne MP and Bradlow HL: Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst. 84:634–638. 1992. View Article : Google Scholar : PubMed/NCBI | |
Bay BH, Jin R, Huang J and Tan PH: Metallothionein as a prognostic biomarker in breast cancer. Exp Biol Med (Maywood). 231:1516–1521. 2006. View Article : Google Scholar : PubMed/NCBI | |
Si M and Lang J: The roles of metallothioneins in carcinogenesis. J Hematol Oncol. 11:1072018. View Article : Google Scholar : PubMed/NCBI | |
Lai Y, Yip GW and Bay BH: Targeting metallothionein for prognosis and treatment of breast cancer. Recent Pat Anticancer Drug Discov. 6:178–185. 2011. View Article : Google Scholar : PubMed/NCBI | |
Jin R, Chow VT, Tan PH, Dheen ST, Duan W and Bay BH: Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis. 23:81–86. 2002. View Article : Google Scholar : PubMed/NCBI | |
Nascimento H, Coy CS, Teori MT, Boin IF, Goes JR, Costa FF and Lima CS: Possible influence of glutathione S-transferase GSTT1 null genotype on age of onset of sporadic colorectal adenocarcinoma. Dis Colon Rectum. 46:510–515. 2003. View Article : Google Scholar : PubMed/NCBI | |
Rebbeck TR: Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 6:733–743. 1997.PubMed/NCBI | |
Dalhoff K, Buus Jensen K and Enghusen Poulsen H: Cancer and molecular biomarkers of phase 2. Methods Enzymol. 400:618–627. 2005. View Article : Google Scholar : PubMed/NCBI | |
Slattery ML, Curtin K, Ma K, Schaffer D, Potter J and Samowitz W: GSTM-1 and NAT2 and genetic alterations in colon tumors. Cancer Causes Control. 13:527–534. 2002. View Article : Google Scholar : PubMed/NCBI | |
Liu X, Li Z, Zhang Z, Zhang W, Li W, Xiao Z, Liu H, Jiao H, Wang Y and Li G: Meta-analysis of GSTM1 null genotype and lung cancer risk in Asians. Med Sci Monit. 20:1239–1245. 2014. View Article : Google Scholar : PubMed/NCBI | |
Yu C, Hequn C, Longfei L, Long W, Zhi C, Feng Z, Jinbo C, Chao L and Xiongbing Z: GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis. Oncotarget. 8:3246–3258. 2017. View Article : Google Scholar : PubMed/NCBI | |
Martignano F, Gurioli G, Salvi S, Calistri D, Costantini M, Gunelli R, De Giorgi U, Foca F and Casadio V: GSTP1 methylation and protein expression in prostate cancer: Diagnostic implications. Dis Markers. 2016:43582922016. View Article : Google Scholar : PubMed/NCBI | |
Gamage N, Barnett A, Hempel N, Duggleby RG, Windmill KF, Martin JL and McManus ME: Human sulfotransferases and their role in chemical metabolism. Toxicol Sci. 90:5–22. 2006. View Article : Google Scholar : PubMed/NCBI | |
Paul P, Suwan J, Liu J, Dordick JS and Linhardt RJ: Recent advances in sulfotransferase enzyme activity assays. Anal Bioanal Chem. 403:1491–1500. 2012. View Article : Google Scholar : PubMed/NCBI | |
Hajishengallis GN and Apostolopoulos AX: Glucosyltransferase (GTF) and immunization against dental caries in humans. Odontostomatol Proodos. 43:315–321. 1989.(In Modern Greek). PubMed/NCBI | |
Breton C, Snajdrova L, Jeanneau C, Koca J and Imberty A: Structures and mechanisms of glycosyltransferases. Glycobiology. 16:29R–37R. 2006. View Article : Google Scholar : PubMed/NCBI | |
Maiti S and Nazmeen A: Impaired redox regulation of estrogen metabolizing proteins is important determinant of human breast cancers. Cancer Cell Int. 19:1112019. View Article : Google Scholar : PubMed/NCBI | |
Subbarayan K and Seliger B: Tumor-dependent effects of proteoglycans and various glycosaminoglycan synthesizing enzymes and sulfotransferases on patients' outcome. Curr Cancer Drug Targets. 19:210–221. 2019. View Article : Google Scholar : PubMed/NCBI | |
Collier AC, Yamauchi Y, Sato BL, Rougee LR and Ward MA: UDP-glucuronosyltransferase 1a enzymes are present and active in the mouse blastocyst. Drug Metab Dispos. 42:1921–1925. 2014. View Article : Google Scholar : PubMed/NCBI | |
Kirkman H: Estrogen-induced tumors of the kidney. III. Growth characteristics in the Syrian hamster. Natl Cancer Inst Monogr. 1:1–57. 1959.PubMed/NCBI | |
Li JJ, Li SA, Klicka JK, Parsons JA and Lam LK: Relative carcinogenic activity of various synthetic and natural estrogens in the Syrian hamster kidney. Cancer Res. 43:5200–5204. 1983.PubMed/NCBI | |
Liehr JG, Fang WF, Sirbasku DA and Ari-Ulubelen A: Carcinogenicity of catechol estrogens in syrian hamsters. J Steroid Biochem. 24:353–356. 1986. View Article : Google Scholar : PubMed/NCBI | |
Liehr JG and Ricci MJ: 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci USA. 93:3294–3296. 1996. View Article : Google Scholar : PubMed/NCBI | |
Zhu BT and Conney AH: Functional role of estrogen metabolism in target cells: Review and perspectives. Carcinogenesis. 19:1–27. 1998. View Article : Google Scholar : PubMed/NCBI | |
Palackal NT, Lee SH, Harvey RG, Blair IA and Penning TM: Activation of polycyclic aromatic hydrocarbon trans-dihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional overexpression in human lung carcinoma (A549) cells. J Biol Chem. 277:24799–24808. 2002. View Article : Google Scholar : PubMed/NCBI | |
Satoh T and Gupta RC: Anticholinesterase Pesticides: Metabolism, Neurotoxicity, and Epidemiologyed. John Wiley & Sons; pp. 6442011 | |
Barski OA, Tipparaju SM and Bhatnagar A: The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. Drug Metab Rev. 40:553–624. 2008. View Article : Google Scholar : PubMed/NCBI | |
Raif A, Marshall GM, Bell JL, Koach J, Tan O, D'Andreti C, Thomas W, Sekyere E, Norris M, Haber M, et al: The estrogen-responsive B box protein (EBBP) restores retinoid sensitivity in retinoid-resistant cancer cells via effects on histone acetylation. Cancer Lett. 277:82–90. 2009. View Article : Google Scholar : PubMed/NCBI | |
Lasram MM, Bouzid K, Douib IB, Annabi A, El Elj N, El Fazaa S, Abdelmoula J and Gharbi N: Lipid metabolism disturbances contribute to insulin resistance and decrease insulin sensitivity by malathion exposure in Wistar rat. Drug Chem Toxicol. 38:227–234. 2015. View Article : Google Scholar : PubMed/NCBI | |
Rahimi R and Abdollahi M: A review on the mechanisms involved in hyperglycemia induced by organophosphorus pesticides. Pest Biochem Physiol. 88:115–121. 2007. View Article : Google Scholar | |
Lasram MM, Annabi AB, El Elj N, Selmi S, Kamoun A, El-Fazaa S and Gharbi N: Metabolic disorders of acute exposure to malathion in adult Wistar rats. J Hazard Mater. 163:1052–1055. 2009. View Article : Google Scholar : PubMed/NCBI | |
Lasram MM, Annabi AB, Rezg R, Elj N, Selmi S, Kamoun A, El-Fazaa S and Gharbi N: Effect of short-time malathion administration on glucose homeostasis in Wistar rat. Pestic Biochem Phys. 92:114–119. 2008. View Article : Google Scholar | |
Panahi P, Vosough-Ghanbari S, Pournourmohammadi S, Ostad SN, Nikfar S, Minaie B and Abdollahi M: Stimulatory effects of malathion on the key enzymes activities of insulin secretion in langerhans islets, glutamate dehydrogenase and glucokinase. Toxicol Mech Methods. 16:161–167. 2006. View Article : Google Scholar : PubMed/NCBI | |
Abdollahi M, Donyavi M, Pournourmohammadi S and Saadat M: Hyperglycemia associated with increased hepatic glycogen phosphorylase and phosphoenolpyruvate carboxykinase in rats following subchronic exposure to malathion. Comp Biochem Physiol C Toxicol Pharmacol. 137:343–347. 2004. View Article : Google Scholar : PubMed/NCBI | |
Kalender S, Uzun FG, Durak D, Demir F and Kalender Y: Malathion-induced hepatotoxicity in rats: The effects of vitamins C and E. Food Chem Toxicol. 48:633–638. 2010. View Article : Google Scholar : PubMed/NCBI | |
Rezg R, Mornagui B, Benahmed M, Chouchane SG, Belhajhmida N, Abdeladhim M, Kamoun A, El-fazaa S and Gharbi N: Malathion exposure modulates hypothalamic gene expression and induces dyslipedemia in Wistar rats. Food Chem Toxicol. 48:1473–1477. 2010. View Article : Google Scholar : PubMed/NCBI | |
Lassiter TL, Ryde IT, Levin ED, Seidler FJ and Slotkin TA: Neonatal exposure to parathion alters lipid metabolism in adulthood: Interactions with dietary fat intake and implications for neurodevelopmental deficits. Brain Res Bull. 81:85–91. 2010. View Article : Google Scholar : PubMed/NCBI | |
Fang H and Judd RL: Adiponectin regulation and function. Compr Physiol. 8:1031–1063. 2018. View Article : Google Scholar : PubMed/NCBI | |
Josephs SF, Ichim TE, Prince SM, Kesari S, Marincola FM, Escobedo AR and Jafri A: Unleashing endogenous TNF-alpha as a cancer immunotherapeutic. J Transl Med. 16:2422018. View Article : Google Scholar : PubMed/NCBI | |
Wajant H: The role of TNF in cancer. Results Probl Cell Differ. 49:1–15. 2009. View Article : Google Scholar : PubMed/NCBI | |
Wang H and Wang WJ: Relationship between CYP1A1 polymorphisms and invasion and metastasis of breast cancer. Asian Pac J Trop Med. 6:835–838. 2013. View Article : Google Scholar : PubMed/NCBI | |
Broustas CG and Lieberman HB: DNA damage response genes and the development of cancer metastasis. Radiat Res. 181:111–130. 2014. View Article : Google Scholar : PubMed/NCBI | |
Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC and Weinberg RA: Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 15:50–65. 2001. View Article : Google Scholar : PubMed/NCBI | |
Schubbert S, Shannon K and Bollag G: Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer. 7:295–308. 2007. View Article : Google Scholar : PubMed/NCBI | |
Roy D, Calaf G and Hei TK: Allelic imbalance at 11p15.5-15.4 correlated with c-Ha-ras mutation during radiation-induced neoplastic transformation of human breast epithelial cells. Int J Cancer. 103:730–737. 2003. View Article : Google Scholar : PubMed/NCBI | |
Roy D, Calaf G and Hei TK: Frequent allelic imbalance on chromosome 6 and 17 correlate with radiation-induced neoplastic transformation of human breast epithelial cells. Carcinogenesis. 22:1685–1692. 2001. View Article : Google Scholar : PubMed/NCBI | |
Zhang PL, Calaf G and Russo J: Allele loss and point mutation in codons 12 and 61 of the c-Ha-ras oncogene in carcinogen-transformed human breast epithelial cells. Mol Carcinog. 9:46–56. 1994. View Article : Google Scholar : PubMed/NCBI | |
Lin JC, Wang CC, Jiang RS, Wang WY and Liu SA: Microsatellite alteration in head and neck squamous cell carcinoma patients from a betel quid-prevalent region. Sci Rep. 6:226142016. View Article : Google Scholar : PubMed/NCBI | |
Hadziavdic V, Pavlovic-Calic N and Eminovic I: Microsatellite instability and loss of heterozygosity of tumor suppressor genes in Bosnian patients with sporadic colorectal cancer. Bosn J Basic Med Sci. 8:313–321. 2008. View Article : Google Scholar : PubMed/NCBI | |
Chambuso R, Kaambo E, Denny L, Gray CM, Williamson AL, Migdalska-Sek M, Agenbag G, Rebello G and Ramesar R: Investigation of cervical tumor biopsies for chromosomal loss of heterozygosity (LOH) and microsatellite instability (MSI) at the HLA II locus in HIV-1/HPV Co-infected Women. Front Oncol. 9:9512019. View Article : Google Scholar : PubMed/NCBI | |
Boland CR and Goel A: Microsatellite instability in colorectal cancer. Gastroenterology. 138:2073–2087.e3. 2010. View Article : Google Scholar : PubMed/NCBI | |
Kim TM and Park PJ: A genome-wide view of microsatellite instability: Old stories of cancer mutations revisited with new sequencing technologies. Cancer Res. 74:6377–6382. 2014. View Article : Google Scholar : PubMed/NCBI | |
Banys-Paluchowski M, Fehm T, Janni W, Aktas B, Fasching PA, Kasimir-Bauer S, Milde-Langosch K, Pantel K, Rack B, Riethdorf S, et al: Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer. BMC Cancer. 18:5412018. View Article : Google Scholar : PubMed/NCBI | |
Spandidos DA, Karaiossifidi H, Malliri A, Linardopoulos S, Vassilaros S, Tsikkinis A and Field JK: Expression of ras Rb1 and p53 proteins in human breast cancer. Anticancer Res. 12:81–89. 1992.PubMed/NCBI | |
Calaf GM and Abarca-Quinones J: Ras protein expression as a marker for breast cancer. Oncol Lett. 11:3637–3642. 2016. View Article : Google Scholar : PubMed/NCBI | |
Didsbury J, Weber RF, Bokoch GM, Evans T and Snyderman R: Rac, a novel ras-related family of proteins that are botulinum toxin substrates. J Biol Chem. 264:16378–16382. 1989. View Article : Google Scholar : PubMed/NCBI | |
Wennerberg K, Rossman KL and Der CJ: The Ras superfamily at a glance. J Cell Sci. 118:843–846. 2005. View Article : Google Scholar : PubMed/NCBI | |
Fritz G, Brachetti C, Bahlmann F, Schmidt M and Kaina B: Rho GTPases in human breast tumours: Expression and mutation analyses and correlation with clinical parameters. Br J Cancer. 87:635–644. 2002. View Article : Google Scholar : PubMed/NCBI | |
Kleer CG, van Golen KL, Zhang Y, Wu ZF, Rubin MA and Merajver SD: Characterization of RhoC expression in benign and malignant breast disease: A potential new marker for small breast carcinomas with metastatic ability. Am J Pathol. 160:579–584. 2002. View Article : Google Scholar : PubMed/NCBI | |
Bustelo XR, Sauzeau V and Berenjeno IM: GTP-binding proteins of the Rho/Rac family: Regulation, effectors and functions in vivo. Bioessays. 29:356–370. 2007. View Article : Google Scholar : PubMed/NCBI | |
Skowronek KR, Guo F, Zheng Y and Nassar N: The C-terminal basic tail of RhoG assists the guanine nucleotide exchange factor trio in binding to phospholipids. J Biol Chem. 279:37895–37907. 2004. View Article : Google Scholar : PubMed/NCBI | |
Ko CD, Kim JS, Ko BG, Son BH, Kang HJ, Yoon HS, Cho EY, Gong G and Ahn SH: The meaning of the c-kit proto-oncogene product in malignant transformation in human mammary epithelium. Clin Exp Metastasis. 20:593–597. 2003. View Article : Google Scholar : PubMed/NCBI | |
Najafi M, Ahmadi A and Mortezaee K: Extracellular-signal-regulated kinase/mitogen-activated protein kinase signaling as a target for cancer therapy: An updated review. Cell Biol Int. 43:1206–1222. 2019. View Article : Google Scholar : PubMed/NCBI | |
Turner N and Grose R: Fibroblast growth factor signalling: From development to cancer. Nat Rev Cancer. 10:116–129. 2010. View Article : Google Scholar : PubMed/NCBI | |
Carter EP, Fearon AE and Grose RP: Careless talk costs lives: Fibroblast growth factor receptor signalling and the consequences of pathway malfunction. Trends Cell Biol. 25:221–233. 2015. View Article : Google Scholar : PubMed/NCBI | |
Akl MR, Nagpal P, Ayoub NM, Tai B, Prabhu SA, Capac CM, Gliksman M, Goy A and Suh KS: Molecular and clinical significance of fibroblast growth factor 2 (FGF2/bFGF) in malignancies of solid and hematological cancers for personalized therapies. Oncotarget. 7:44735–44762. 2016. View Article : Google Scholar : PubMed/NCBI | |
Wesche J, Haglund K and Haugsten EM: Fibroblast growth factors and their receptors in cancer. Biochem J. 437:199–213. 2011. View Article : Google Scholar : PubMed/NCBI | |
Zakrzewska M, Marcinkowska E and Wiedlocha A: FGF-1: From biology through engineering to potential medical applications. Crit Rev Clin Lab Sci. 45:91–135. 2008. View Article : Google Scholar : PubMed/NCBI | |
Hu Z, Evarts RP, Fujio K, Omori N, Omori M, Marsden ER and Thorgeirsson SS: Expression of transforming growth factor alpha/epidermal growth factor receptor, hepatocyte growth factor/c-met and acidic fibroblast growth factor/fibroblast growth factor receptors during hepatocarcinogenesis. Carcinogenesis. 17:931–938. 1996. View Article : Google Scholar : PubMed/NCBI | |
Chow NH, Cheng KS, Lin PW, Chan SH, Su WC, Sun YN and Lin XZ: Expression of fibroblast growth factor-1 and fibroblast growth factor-2 in normal liver and hepatocellular carcinoma. Dig Dis Sci. 43:2261–2266. 1998. View Article : Google Scholar : PubMed/NCBI | |
Yamanaka Y, Friess H, Buchler M, Beger HG, Uchida E, Onda M, Kobrin MS and Korc M: Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res. 53:5289–5296. 1993.PubMed/NCBI | |
Soufla G, Sifakis S and Spandidos DA: FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium. Cancer Lett. 259:146–155. 2008. View Article : Google Scholar : PubMed/NCBI | |
Watnick RS: The role of the tumor microenvironment in regulating angiogenesis. Cold Spring Harb Perspect Med. 2:a0066762012. View Article : Google Scholar : PubMed/NCBI | |
Schmid C: Insulin-like growth factors. Cell Biol Int. 19:445–457. 1995. View Article : Google Scholar : PubMed/NCBI | |
Baxter RC: Insulin-like growth factor binding proteins as glucoregulators. Metabolism. 44 (10 Suppl 4):S12–S17. 1995. View Article : Google Scholar | |
Kelley KM, Oh Y, Gargosky SE, Gucev Z, Matsumoto T, Hwa V, Ng L, Simpson DM and Rosenfeld RG: Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol. 28:619–637. 1996. View Article : Google Scholar : PubMed/NCBI | |
Oh Y, Nagalla SR, Yamanaka Y, Kim HS, Wilson E and Rosenfeld RG: Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-I and -II. J Biol Chem. 271:30322–30325. 1996. View Article : Google Scholar : PubMed/NCBI | |
Mnif W, Hassine AI, Bouaziz A, Bartegi A, Thomas O and Roig B: Effect of endocrine disruptor pesticides: A review. Int J Environ Res Public Health. 8:2265–2303. 2011. View Article : Google Scholar : PubMed/NCBI | |
Takayama T, Shiozaki H, Shibamoto S, Oka H, Kimura Y, Tamura S, Inoue M, Monden T, Ito F and Monden M: Beta-catenin expression in human cancers. Am J Pathol. 148:39–46. 1996.PubMed/NCBI | |
Breen E, Steele G Jr and Mercurio AM: Role of the E-cadherin/alpha-catenin complex in modulating cell-cell and cell-matrix adhesive properties of invasive colon carcinoma cells. Ann Surg Oncol. 2:378–385. 1995. View Article : Google Scholar : PubMed/NCBI | |
Lim SC and Lee MS: Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer. Oncol Rep. 9:915–928. 2002.PubMed/NCBI | |
Nakopoulou L, Gakiopoulou-Givalou H, Karayiannakis AJ, Giannopoulou I, Keramopoulos A, Davaris P and Pignatelli M: Abnormal alpha-catenin expression in invasive breast cancer correlates with poor patient survival. Histopathology. 40:536–546. 2002. View Article : Google Scholar : PubMed/NCBI | |
Pierceall WE, Woodard AS, Morrow JS, Rimm D and Fearon ER: Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines. Oncogene. 11:1319–1326. 1995.PubMed/NCBI | |
Lewis JA, Szilagyi M, Gehman E, Dennis WE and Jackson DA: Distinct patterns of gene and protein expression elicited by organophosphorus pesticides in Caenorhabditis elegans. BMC Genomics. 10:2022009. View Article : Google Scholar : PubMed/NCBI | |
Williams PL and Dusenbery DB: Using the nematode Caenorhabditis elegans to predict mammalian acute lethality to metallic salts. Toxicol Ind Health. 4:469–478. 1988. View Article : Google Scholar : PubMed/NCBI | |
Morgan PG and Sedensky MM: Mutations affecting sensitivity to ethanol in the nematode, Caenorhabditis elegans. Alcohol Clin Exp Res. 19:1423–1429. 1995. View Article : Google Scholar : PubMed/NCBI | |
Bargmann CI: Neurobiology of the Caenorhabditis elegans genome. Science. 282:2028–2033. 1998. View Article : Google Scholar : PubMed/NCBI | |
Cole RD, Anderson GL and Williams PL: The nematode Caenorhabditis elegans as a model of organophosphate-induced mammalian neurotoxicity. Toxicol Appl Pharmacol. 194:248–256. 2004. View Article : Google Scholar : PubMed/NCBI | |
Jin HJ, Kwon JH, Kim M, Bae YK, Choi SJ, Oh W, Yang YS and Jeon HB: Downregulation of melanoma cell adhesion molecule (MCAM/CD146) accelerates cellular senescence in human umbilical cord blood-derived mesenchymal stem cells. Stem Cells Transl Med. 5:427–439. 2016. View Article : Google Scholar : PubMed/NCBI | |
Leroyer AS, Blin MG, Bachelier R, Bardin N, Blot-Chabaud M and Dignat-George F: CD146 (Cluster of Differentiation 146). Arterioscler Thromb Vasc Biol. 39:1026–1033. 2019. View Article : Google Scholar : PubMed/NCBI | |
Ye Z, Zhang C, Tu T, Sun M, Liu D, Lu D, Feng J, Yang D, Liu F and Yan X: Wnt5a uses CD146 as a receptor to regulate cell motility and convergent extension. Nat Commun. 4:28032013. View Article : Google Scholar : PubMed/NCBI | |
Kang Y, Wang F, Feng J, Yang D, Yang X and Yan X: Knockdown of CD146 reduces the migration and proliferation of human endothelial cells. Cell Res. 16:313–318. 2006. View Article : Google Scholar : PubMed/NCBI | |
Ouhtit A, Gaur RL, Abd Elmageed ZY, Fernando A, Thouta R, Trappey AK, Abdraboh ME, El-Sayyad HI, Rao P and Raj MG: Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146. Biochim Biophys Acta. 1795:130–136. 2009.PubMed/NCBI | |
Coulombe PA and Omary MB: ‘Hard’ and ‘soft’ principles defining the structure, function and regulation of keratin intermediate filaments. Curr Opin Cell Biol. 14:110–122. 2002. View Article : Google Scholar : PubMed/NCBI | |
Greystoke A, Dean E, Saunders MP, Cummings J, Hughes A, Ranson M, Dive C and Renehan AG: Multi-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancer. Br J Cancer. 107:1518–1524. 2012. View Article : Google Scholar : PubMed/NCBI | |
Schneider J: Tumor markers in detection of lung cancer. Adv Clin Chem. 42:1–41. 2006. View Article : Google Scholar : PubMed/NCBI | |
Moll R, Divo M and Langbein L: The human keratins: Biology and pathology. Histochem Cell Biol. 129:705–733. 2008. View Article : Google Scholar : PubMed/NCBI | |
Ahn SK, Moon HG, Ko E, Kim HS, Shin HC, Kim J, You JM, Han W and Noh DY: Preoperative serum tissue polypeptide-specific antigen is a valuable prognostic marker in breast cancer. Int J Cancer. 132:875–881. 2013. View Article : Google Scholar : PubMed/NCBI | |
Escobar-Hoyos LF, Shah R, Roa-Pena L, Vanner EA, Najafian N, Banach A, Nielsen E, Al-Khalil R, Akalin A, Talmage D, et al: Keratin-17 promotes p27KIP1 nuclear export and degradation and offers potential prognostic utility. Cancer Res. 75:3650–3662. 2015. View Article : Google Scholar : PubMed/NCBI | |
Tan HS, Jiang WH, He Y, Wang DS, Wu ZJ, Wu DS, Gao L, Bao Y, Shi JZ, Liu B, et al: KRT8 upregulation promotes tumor metastasis and is predictive of a poor prognosis in clear cell renal cell carcinoma. Oncotarget. 8:76189–76203. 2017. View Article : Google Scholar : PubMed/NCBI | |
Cheung KJ, Padmanaban V, Silvestri V, Schipper K, Cohen JD, Fairchild AN, Gorin MA, Verdone JE, Pienta KJ, Bader JS and Ewald AJ: Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters. Proc Natl Acad Sci USA. 113:E854–E863. 2016. View Article : Google Scholar : PubMed/NCBI | |
Saha SK, Choi HY, Kim BW, Dayem AA, Yang GM, Kim KS, Yin YF and Cho SG: KRT19 directly interacts with beta-catenin/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties. Oncogene. 36:332–349. 2017. View Article : Google Scholar : PubMed/NCBI | |
Zhang B, Wang J, Liu W, Yin Y, Qian D, Zhang H, Shi B, Li C, Zhu J, Zhang L, et al: Cytokeratin 18 knockdown decreases cell migration and increases chemosensitivity in non-small cell lung cancer. J Cancer Res Clin Oncol. 142:2479–2487. 2016. View Article : Google Scholar : PubMed/NCBI | |
Yin B, Zhang M, Zeng Y, Li Y, Zhang C, Getzenberg RH and Song Y: Downregulation of cytokeratin 18 is associated with paclitaxelresistance and tumor aggressiveness in prostate cancer. Int J Oncol. 48:1730–1736. 2016. View Article : Google Scholar : PubMed/NCBI | |
Miller DJ and Fort PE: Heat shock proteins regulatory role in neurodevelopment. Front Neurosci. 12:8212018. View Article : Google Scholar : PubMed/NCBI | |
Schlesinger MJ, Ashburner M and Tissières A: Heat Shock: From bacteria to man. Cold Spring Harbor Laboratory; Cold Spring Harbor, NY: 1982 | |
Zeilstra-Ryalls J, Fayet O and Georgopoulos C: The universally conserved GroE (Hsp60) chaperonins. Annu Rev Microbiol. 45:301–325. 1991. View Article : Google Scholar : PubMed/NCBI | |
Georgopoulos C and Welch WJ: Role of the major heat shock proteins as molecular chaperones. Annu Rev Cell Biol. 9:601–634. 1993. View Article : Google Scholar : PubMed/NCBI | |
Ohtsuka K: Cloning of a cDNA for heat-shock protein hsp40, a human homologue of bacterial DnaJ. Biochem Biophys Res Commun. 197:235–240. 1993. View Article : Google Scholar : PubMed/NCBI | |
Todd MJ, Viitanen PV and Lorimer GH: Dynamics of the chaperonin ATPase cycle: Implications for facilitated protein folding. Science. 265:659–566. 1994. View Article : Google Scholar : PubMed/NCBI | |
Meher PK, Sahu TK, Gahoi S and Rao AR: ir-HSP: Improved recognition of heat shock proteins, their families and sub-types based On g-Spaced Di-peptide features and support vector machine. Front Genet. 8:2352017. View Article : Google Scholar : PubMed/NCBI | |
Lee CH, Hong HM, Chang YY and Chang WW: Inhibition of heat shock protein (Hsp) 27 potentiates the suppressive effect of Hsp90 inhibitors in targeting breast cancer stem-like cells. Biochimie. 94:1382–1389. 2012. View Article : Google Scholar : PubMed/NCBI | |
Werner I, Koger CS, Hamm JT and Hinton DE: Ontogeny of the heat shock protein, hsp70 and hsp60, response and developmental effects of heat-shock in the teleost, medaka (Oryzias latipes). Environmental Sci. 8:13–29. 2001. | |
Levine AJ, Momand J and Finlay CA: The p53 tumour suppressor gene. Nature. 351:453–456. 1991. View Article : Google Scholar : PubMed/NCBI | |
Callahan R: p53 mutations, another breast cancer prognostic factor. J Natl Cancer Inst. 84:826–827. 1992. View Article : Google Scholar : PubMed/NCBI | |
Moll UM, Ostermeyer AG, Ahomadegbe JC, Mathieu MC and Riou G: p53 mediated tumor cell response to chemotherapeutic DNA damage: A preliminary study in matched pairs of breast cancer biopsies. Hum Pathol. 26:1293–1301. 1995. View Article : Google Scholar : PubMed/NCBI | |
Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, et al: Mutations in the p53 gene occur in diverse human tumour types. Nature. 342:705–708. 1989. View Article : Google Scholar : PubMed/NCBI | |
Migdalska-Sek M, Pastuszak-Lewandoska D and Brzezianska E: MSI and LOH in the development and prognosis of follicular cell-derived thyroid tumours. Endokrynol Pol. 63:126–136. 2012.PubMed/NCBI | |
Kiaris H and Spandidos D: Mutations of ras genes in human tumors (review). Int J Oncol. 7:413–421. 1995.PubMed/NCBI | |
Samowitz WS, Holden JA, Curtin K, Edwards SL, Walker AR, Lin HA, Robertson MA, Nichols MF, Gruenthal KM, Lynch BJ, et al: Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer. Am J Pathol. 158:1517–1524. 2001. View Article : Google Scholar : PubMed/NCBI | |
Mendez O, Manas S, Peinado, Fabra A, Escobedo A, Moreno A and Sierra A: Microsatellite instability is associated with the loss of apoptosis in ductal breast carcinomas. Breast Cancer Res Treat. 65:171–177. 2001. View Article : Google Scholar : PubMed/NCBI | |
Appella E and Anderson CW: Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem. 268:2764–2772. 2001. View Article : Google Scholar : PubMed/NCBI | |
Lee E, Oh E and Lee J, Sul D and Lee J: Use of the tail moment of the lymphocytes to evaluate DNA damage in human biomonitoring studies. Toxicol Sci. 81:121–132. 2004. View Article : Google Scholar : PubMed/NCBI | |
Kumar N, Yadav A, Gulati S, Priya K, Aggarwal N and Gupta R: Effects of GST polymorphism on ameliorative effect of curcumin and carvacrol against DNA damage induced by combined treatment of malathion and parathion. IJT. 10:19–27. 2016. View Article : Google Scholar | |
Collins AR: The comet assay for DNA damage and repair: Principles, applications, and limitations. Mol Biotechnol. 26:249–261. 2004. View Article : Google Scholar : PubMed/NCBI | |
Moore PD, Yedjou CG and Tchounwou PB: Malathion-induced oxidative stress, cytotoxicity, and genotoxicity in human liver carcinoma (HepG2) cells. Environ Toxicol. 25:221–226. 2010. View Article : Google Scholar : PubMed/NCBI |